An appraisal of natural products active against parasitic nematodes of animals

Abstract Here, the scientific and patent literature on the activities of purified natural compounds has been reviewed, with the aim of assessing their suitability as anthelmintic drug discovery starting points. Only compounds described as active against parasitic nematodes of animals or against the...

Full description

Bibliographic Details
Main Authors: Jose F. Garcia-Bustos, Brad E. Sleebs, Robin B. Gasser
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Parasites & Vectors
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13071-019-3537-1
id doaj-b14af5b8c2d447e7bea5fcfc07284582
record_format Article
spelling doaj-b14af5b8c2d447e7bea5fcfc072845822020-11-25T03:50:06ZengBMCParasites & Vectors1756-33052019-06-0112112210.1186/s13071-019-3537-1An appraisal of natural products active against parasitic nematodes of animalsJose F. Garcia-Bustos0Brad E. Sleebs1Robin B. Gasser2Faculty of Veterinary and Agricultural Sciences, The University of MelbourneWalter and Eliza Hall Institute of Medical ResearchFaculty of Veterinary and Agricultural Sciences, The University of MelbourneAbstract Here, the scientific and patent literature on the activities of purified natural compounds has been reviewed, with the aim of assessing their suitability as anthelmintic drug discovery starting points. Only compounds described as active against parasitic nematodes of animals or against the model nematode Caenorhabditis elegans have been analysed. Scientific articles published since 2010 and patents granted from 2000, both inclusive, have been included in this analysis. The results show a scarcity of novel chemical structures, a limited follow-up of compounds disclosed before 2010 and a bias towards the screening of plant products, almost to the exclusion of other sources, when microbial extracts have, historically, provided most starting points for anti-infective drugs. All plant products published in this period were previously known, alerting to the high re-discovery rates of a limited number of chemical classes from this source. The most promising compounds described in the literature reviewed here, namely the linear nemadectin-derivatives, are novel and of bacterial origin. Patented but otherwise unpublished spiroketal structures also appear as interesting scaffolds for future development. The patent literature confirmed that it is possible to patent derivatives of previously known products, making them valid starting points for translational research.http://link.springer.com/article/10.1186/s13071-019-3537-1AnimalsAnthelminticsNatural productsNematocides
collection DOAJ
language English
format Article
sources DOAJ
author Jose F. Garcia-Bustos
Brad E. Sleebs
Robin B. Gasser
spellingShingle Jose F. Garcia-Bustos
Brad E. Sleebs
Robin B. Gasser
An appraisal of natural products active against parasitic nematodes of animals
Parasites & Vectors
Animals
Anthelmintics
Natural products
Nematocides
author_facet Jose F. Garcia-Bustos
Brad E. Sleebs
Robin B. Gasser
author_sort Jose F. Garcia-Bustos
title An appraisal of natural products active against parasitic nematodes of animals
title_short An appraisal of natural products active against parasitic nematodes of animals
title_full An appraisal of natural products active against parasitic nematodes of animals
title_fullStr An appraisal of natural products active against parasitic nematodes of animals
title_full_unstemmed An appraisal of natural products active against parasitic nematodes of animals
title_sort appraisal of natural products active against parasitic nematodes of animals
publisher BMC
series Parasites & Vectors
issn 1756-3305
publishDate 2019-06-01
description Abstract Here, the scientific and patent literature on the activities of purified natural compounds has been reviewed, with the aim of assessing their suitability as anthelmintic drug discovery starting points. Only compounds described as active against parasitic nematodes of animals or against the model nematode Caenorhabditis elegans have been analysed. Scientific articles published since 2010 and patents granted from 2000, both inclusive, have been included in this analysis. The results show a scarcity of novel chemical structures, a limited follow-up of compounds disclosed before 2010 and a bias towards the screening of plant products, almost to the exclusion of other sources, when microbial extracts have, historically, provided most starting points for anti-infective drugs. All plant products published in this period were previously known, alerting to the high re-discovery rates of a limited number of chemical classes from this source. The most promising compounds described in the literature reviewed here, namely the linear nemadectin-derivatives, are novel and of bacterial origin. Patented but otherwise unpublished spiroketal structures also appear as interesting scaffolds for future development. The patent literature confirmed that it is possible to patent derivatives of previously known products, making them valid starting points for translational research.
topic Animals
Anthelmintics
Natural products
Nematocides
url http://link.springer.com/article/10.1186/s13071-019-3537-1
work_keys_str_mv AT josefgarciabustos anappraisalofnaturalproductsactiveagainstparasiticnematodesofanimals
AT bradesleebs anappraisalofnaturalproductsactiveagainstparasiticnematodesofanimals
AT robinbgasser anappraisalofnaturalproductsactiveagainstparasiticnematodesofanimals
AT josefgarciabustos appraisalofnaturalproductsactiveagainstparasiticnematodesofanimals
AT bradesleebs appraisalofnaturalproductsactiveagainstparasiticnematodesofanimals
AT robinbgasser appraisalofnaturalproductsactiveagainstparasiticnematodesofanimals
_version_ 1724492323711090688